Skip to content
LATEST
Health

South Africa Faces Critical Shortages of Essential Medicines

South Africa is experiencing a critical shortage of 50 essential medicines due to domestic regulatory backlogs and global supply chain disruptions…

South Africa Faces Critical Shortages of Essential Medicines

Public healthcare facilities across South Africa are experiencing a systemic shortage of approximately 50 critical medicines, severely disrupting treatment for chronic and acute conditions. The supply deficit spans a broad spectrum of medical needs, including oncology, neurology, psychiatry, respiratory health, and infectious disease management. Patients are currently facing significant delays in accessing essential treatments for conditions such as epilepsy, schizophrenia, bipolar disorder, and tuberculosis.

Department of Health is attempting to mitigate the crisis by sourcing therapeutic alternatives and issuing special authorizations for the emergency importation of restricted drugs. Despite these efforts, internal reports indicate that the rate of new shortages is outpacing the resolution of existing supply gaps. This instability is placing extreme pressure on already overstretched public clinics and hospitals, which serve as the primary point of care for the country's most vulnerable populations.

These internal issues are compounded by global supply

Regional health authorities have identified a combination of domestic and international factors driving the crisis. Domestic challenges include manufacturing bottlenecks, regulatory delays, and significant backlogs in customs and medicine testing. These internal issues are compounded by global supply chain instability, particularly the ongoing conflict in the Middle East, which has disrupted critical shipping and air-cargo routes.

These logistical disruptions have specifically impacted the distribution of generic medicines and pharmaceutical ingredients from major suppliers in Asia. The resulting increase in freight costs and extended delivery timelines has left countries with limited stock reserves, such as South Africa, highly susceptible to prolonged supply failures. Policymakers are now facing increased pressure to implement structural interventions to stabilize the pharmaceutical supply chain and prevent further degradation of public health outcomes.

More stories

Latest news